Amiodarone Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.
Conditions:   Ventricular Tachycardia;   Ventricular Fibrillation Interventions:   Drug: Nifekalant hydrochloride;   Drug: Amiodarone Sponsor:   Sichuan Baili Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2019 Category: Research Source Type: clinical trials